Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (383) clinical trials

To compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing multiple sclerosis

Phase

Subjects with RRMS who have experienced a relapse and who will receive 3 to 5 (given over a period of up to 7 days) days of treatment with high dose steroids (oral or IV) within 10 days of the onset of relapse symptoms are candidates for the current study. At ...

Phase

Study Purpose: This is an observational study in men and women (patients >18 years old) who have been diagnosed with multiple sclerosis. The purpose of this study is to better characterize the long-term benefits and risks of dimethyl fumarate (DMF) medication in patients with multiple sclerosis (MS) who are prescribed ...

Phase

The purpose of this study is to monitor the safety profile of an approved medication called fingolimod compared to other approved medications for the treatment of multiple sclerosis. This is a mulitnational study which will include approximately 2400 patients. It is an observational study of patients who will be starting ...

Phase

Local doctors are looking for people with Multiple Sclerosis (MS) for clinical research studies of an investigational medication. Compensation provided for time and travel!

Phase N/A

The proposed study utilizes a prospective, non-interventional, observational cohort study design to evaluate the necessary duration of monitoring following treatment with LEMTRADA and to further inform appropriate monitoring conditions. It will evaluate the long term safety profile, particularly the AESI incidence rates over time in RMS patients, to accomplish the ...

Phase N/A

6.1 PRIMARY The primary objective of the study is to evaluate treatment satisfaction as the primary Patient- Reported Outcome (PRO) in patients with relapsing forms of MS (RMS) treated with LEMTRADA in a real life setting using the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4. 6.2 SECONDARY The secondary ...

Phase N/A

The purpose of this study is to measure safe and tolerable doses of rHIgM22 in patients with MS immediately following a relapse.

Phase

The purpose of this study is to characterize the full pharmacokinetic and pharmacodynamics profiles of RPC1063 in patients with relapsing multiple sclerosis (RMS).

Phase